Brimonidine Tartrate

Product manufactured by Sandoz Inc

Application Nr Approved Date Route Status External Links
NDA021764 None Ophthalmic None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Brimonidine Tartrate Ophthalmic Solution, 0.15% Is Indicated For The Lowering Of Intraocular Pressure In Patients With Open-Angle Glaucoma Or Ocular Hypertension. Brimonidine Tartrate Ophthalmic Solution, 0.15% Is An Alpha-2 Adrenergic Receptor Agonist Indicated For The Lowering Of Intraocular Pressure In Patients With Open-Angle Glaucoma Or Ocular Hypertension ( 1 ).

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Brimonidine Tartrate BRIMONIDINE TARTRATE ZINC895301

Comments